Company Name: |
Energy Chemical
|
Tel: |
021-58432009 400-005-6266 |
Email: |
marketing1@energy-chemical.com |
Products Intro: |
Product Name:Saxagliptin N-Carboxybenzyl CAS:1408335-73-8 Purity:NULL Package:1mg;25mg;5mg Remarks:NULL
|
Company Name: |
QUALITY CONTROL SOLUTIONS LTD.
|
Tel: |
13670046396 |
Email: |
ORDERS@QCSRM.COM |
Products Intro: |
Product Name:Saxagliptin Impurity 54 CAS:1408335-73-8 Purity:95% HPLC Package:10MG;25MG;50MG;100MG
|
Company Name: |
CLEARSYNTH LABS LTD.
|
Tel: |
+91-22-45045900 |
Email: |
sales@clearsynth.com |
Products Intro: |
Product Name:Saxagliptin N-Carboxybenzyl CAS:1408335-73-8
|
|
| DSLXQSYLYSTVKT-ONZQNKQFSA-N Basic information |
Product Name: | DSLXQSYLYSTVKT-ONZQNKQFSA-N | Synonyms: | DSLXQSYLYSTVKT-ONZQNKQFSA-N;Carbamic acid, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-, phenylmethyl ester;Saxagliptin Impurity 54 | CAS: | 1408335-73-8 | MF: | C26H31N3O4 | MW: | 449.54 | EINECS: | | Product Categories: | | Mol File: | 1408335-73-8.mol | ![DSLXQSYLYSTVKT-ONZQNKQFSA-N Structure](CAS/20180808/GIF/1408335-73-8.gif) |
| DSLXQSYLYSTVKT-ONZQNKQFSA-N Chemical Properties |
Boiling point | 694.7±50.0 °C(Predicted) | density | 1.35±0.1 g/cm3(Predicted) | solubility | soluble in Chloroform, DCM, Ethyl Acetate, Methanol | form | Solid | pka | 11.24±0.46(Predicted) | color | White |
| DSLXQSYLYSTVKT-ONZQNKQFSA-N Usage And Synthesis |
Uses | Saxagliptin N-Carboxybenzyl is an intermediate in the synthesis of derivatives of Saxagliptin (S143500), a potent dipeptidyl peptidase-4 inhibitor approved for the treatment of type 2 diabetes mellitus. |
| DSLXQSYLYSTVKT-ONZQNKQFSA-N Preparation Products And Raw materials |
|
Tag:DSLXQSYLYSTVKT-ONZQNKQFSA-N(1408335-73-8)
Related Product Information
|
BOC-DL-PROLINE ETHYL ESTER
(1R,3S,5R)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXAMIDE 2,2,2-TRIFLUOROACETIC ACID
(1S,3R,5S)-2-tert-Butyl 3-ethyl 2-azabicyclo[3.1.0]hexane-2,3-dicarboxylate
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)-
Saxagliptin hydrochloride
1H-Pyrrole-1-carboxylic acid, 2-(aMinocarbonyl)-2,3-dihydro-, 1,1-diMethylethyl ester, (2S)-
(S) - N- Boc- adamantylglycine
(S)-1-Boc-2,3-dihydro-2-pyrrolecarboxylic acid ethyl ester
2-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic acid, 2-(1,1-dimethylethyl) 3-ethyl ester, (1S,3S,5S)-
N-Boc-L-trans-4,5-Methanoproline
(2R)-1,2-Pyrrolidinedicarboxylic acid 1-tert-butyl 2-ethyl ester
(1S,3S,5S)-2-(TERT-BUTOXYCARBONYL)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXYLIC ACID
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)-
AcetaMide, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-2,2,2-trifluoro-
Saxagliptin O-β-D-glucuronide
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)-
N-Boc-L-trans-4,5-methanoproline ethyl ester
|